- Bloomberg•last year
Mallinckrodt Plc’s Questcor Pharmaceuticals Inc. faces a multistate antitrust investigation, according to a Texas attorney general’s office letter revealing that state’s participation in the probe. Texas said that, as of last month, it “anticipated being involved” in the multistate case, according to the June 12 letter, a response to a freedom of information request in May. Katherine Wise, a spokeswoman for Texas Attorney General Ken Paxton, authenticated the letter while declining to comment further on the probe.
- Zacks•last year
Mallinckrodt plc (MNK) reported adjusted earnings of $1.72 per share in the second quarter of fiscal 2015 easily beating the Zacks Consensus Estimate of $1.48.
- Associated Press•2 years ago
Shares of Mallinckrodt PLC rose Tuesday after the health care products maker posted an earnings outlook for next year that beat Wall Street expectations. The Dublin-based company expects adjusted earnings ...
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|